Search Results

There are 9824 results for: content related to: Predictors of long-term outcome in multiple sclerosis patients treated with interferon beta

  1. You have free access to this content
    New natural history of interferon-β–treated relapsing multiple sclerosis

    Annals of Neurology

    Volume 61, Issue 4, April 2007, Pages: 300–306, Maria Trojano, Fabio Pellegrini, Aurora Fuiani, Damiano Paolicelli, Valentina Zipoli, Giovanni B. Zimatore, Elisabetta Di Monte, Emilio Portaccio, Vito Lepore, Paolo Livrea and Maria Pia Amato

    Version of Record online : 19 APR 2007, DOI: 10.1002/ana.21102

  2. A prospective, open-label treatment trial to compare the effect of IFN β-1a (Avonex), IFNβ-1b (Betaseron), and glatiramer acetate (Copaxone) on the relapse rate in relapsing-remitting multiple sclerosis

    European Journal of Neurology

    Volume 8, Issue 2, March 2001, Pages: 141–148, O. A. Khan, A. C. Tselis, J. A. Kamholz, J. Y. Garbern, R. A. Lewis and R. P. Lisak

    Version of Record online : 7 JUL 2008, DOI: 10.1046/j.1468-1331.2001.00189.x

  3. You have full text access to this OnlineOpen article
    Beta-interferon exposure and onset of secondary progressive multiple sclerosis

    European Journal of Neurology

    Volume 22, Issue 6, June 2015, Pages: 990–1000, T. Zhang, A. Shirani, Y. Zhao, M. E. Karim, P. Gustafson, J. Petkau, C. Evans, E. Kingwell, M. van der Kop, F. Zhu, J. Oger, H. Tremlett and BC MS Clinic Neurologists

    Version of Record online : 6 APR 2015, DOI: 10.1111/ene.12698

  4. Effectiveness of interferon beta treatment in relapsing-remitting multiple sclerosis: an Italian cohort study

    Journal of Evaluation in Clinical Practice

    Volume 10, Issue 4, November 2004, Pages: 511–518, Pierluigi Russo, Andrea Paolillo, Luciano Caprino, Stefano Bastianello and Placido Bramanti

    Version of Record online : 8 OCT 2004, DOI: 10.1111/j.1365-2753.2003.00436.x

  5. IFNβ impairs extracellular matrix formation leading to inhibition of mineralization by effects in the early stage of human osteoblast differentiation

    Journal of Cellular Physiology

    Volume 227, Issue 6, June 2012, Pages: 2668–2676, V.J. Woeckel, M. Eijken, J. van de Peppel, H. Chiba, B.C.J. van der Eerden and J.P.T.M. van Leeuwen

    Version of Record online : 24 FEB 2012, DOI: 10.1002/jcp.23009

  6. You have free access to this content
    Cost-Effectiveness of Disease-Modifying Therapies in the Management of Multiple Sclerosis for the Medicare Population

    Value in Health

    Volume 12, Issue 5, July/August 2009, Pages: 657–665, Paul Tappenden, Christopher McCabe, Jim Chilcott, Emma Simpson, Richard Nixon, Jason Madan, John D. Fisk and Murray Brown

    Version of Record online : 12 JAN 2009, DOI: 10.1111/j.1524-4733.2008.00485.x

  7. Therapeutic outcome 3 years after switching of immunomodulatory therapies in patients with relapsing–remitting multiple sclerosis in Argentina

    European Journal of Neurology

    Volume 15, Issue 4, April 2008, Pages: 386–393, A. Carrá, P. Onaha, G. Luetic, M. Burgos, E. Crespo, N. Deri, M. Halfon, G. Jaacks, A. López, V. Sinay and C. Vrech

    Version of Record online : 18 MAR 2008, DOI: 10.1111/j.1468-1331.2008.02071.x

  8. Implication of the toll-like receptor 4 pathway in the response to interferon-β in multiple sclerosis

    Annals of Neurology

    Volume 70, Issue 4, October 2011, Pages: 634–645, Marta F. Bustamante, Nicolás Fissolo, Jordi Río, Carmen Espejo, Carme Costa, María José Mansilla, Ignacio Lizasoain, María Angeles Moro, Mari Carmen Edo, Xavier Montalban and Manuel Comabella

    Version of Record online : 25 OCT 2011, DOI: 10.1002/ana.22511

  9. MxA protein – an interferon beta biomarker in primary progressive multiple sclerosis patients

    European Journal of Neurology

    Volume 15, Issue 8, August 2008, Pages: 822–826, A. Millonig, A. Dressel, D. Bahner, A. Bitsch, T. Bogumil, E. Elitok, B. Kitze, H. Tumani, F. Weber, C. Gneiss and F. Deisenhammer

    Version of Record online : 28 JUN 2008, DOI: 10.1111/j.1468-1331.2008.02190.x

  10. Real-life impact of early interferonβ therapy in relapsing multiple sclerosis

    Annals of Neurology

    Volume 66, Issue 4, October 2009, Pages: 513–520, M. Trojano, F. Pellegrini, D. Paolicelli, A. Fuiani, G.B. Zimatore, C. Tortorella, I.L. Simone, F. Patti, A. Ghezzi, V. Zipoli, P. Rossi, C. Pozzilli, G. Salemi, A. Lugaresi, R. Bergamaschi, E. Millefiorini, M. Clerico, G. Lus, M. Vianello, C. Avolio, P. Cavalla, V. Lepore, P. Livrea, G. Comi and M.P. Amato

    Version of Record online : 28 MAY 2009, DOI: 10.1002/ana.21757

  11. Interferon beta-1b treatment in patients with relapsing–remitting multiple sclerosis under a standardized protocol in Spain

    Acta Neurologica Scandinavica

    Volume 102, Issue 4, October 2000, Pages: 209–217, T. Arbizu, J. C. Álvarez-Cermeño, G. Decap, O. Fernández, D. F. Uría, A. García Merino, G. Izquierdo and X. Montalbán

    Version of Record online : 24 DEC 2001, DOI: 10.1034/j.1600-0404.2000.102004209.x

  12. You have full text access to this OnlineOpen article
    A Population Approach to Characterize Interferon Beta-1b Effect on Contrast Enhancing Lesions in Patients With Relapsing Remitting Multiple Sclerosis

    CPT: Pharmacometrics & Systems Pharmacology

    Volume 4, Issue 5, May 2015, Pages: 295–304, A Gulati, F Bagnato, P Villoslada and N Velez de Mendizabal

    Version of Record online : 24 APR 2015, DOI: 10.1002/psp4.36

  13. Nursing Management of MS Patients Receiving Interferon Beta-1b Therapy

    Rehabilitation Nursing

    Volume 22, Issue 2, March-April 1997, Pages: 62–81, Kathleen Costello and Kathleen Conway

    Version of Record online : 10 JUL 2012, DOI: 10.1002/j.2048-7940.1997.tb01735.x

  14. Interferon beta assessment in non-Chinese and Chinese subjects: Pharmacokinetics and pharmacodynamic activity of an endogenous cytokine are not race dependent

    The Journal of Clinical Pharmacology

    Volume 54, Issue 10, October 2014, Pages: 1153–1161, Mark C. Rogge, Yun Liu and Gerald R. Galluppi

    Version of Record online : 23 APR 2014, DOI: 10.1002/jcph.311

  15. Evidence of vitamin D and interferon-β cross-talk in human osteoblasts with 1α,25-dihydroxyvitamin D3 being dominant over interferon-β in stimulating mineralization

    Journal of Cellular Physiology

    Volume 227, Issue 9, September 2012, Pages: 3258–3266, V.J. Woeckel, M. Koedam, J. van de Peppel, H. Chiba, B.C.J. van der Eerden and J.P.T.M. van Leeuwen

    Version of Record online : 17 MAY 2012, DOI: 10.1002/jcp.24020

  16. You have free access to this content
    Cost-Effectiveness Analysis of Interferon Beta in Multiple Sclerosis: A Markov Process Analysis

    Value in Health

    Volume 5, Issue 1, January 2002, Pages: 44–54, Mark J. C. Nuijten and John Hutton

    Version of Record online : 21 MAR 2002, DOI: 10.1046/j.1524-4733.2002.51052.x

  17. You have free access to this content
    Interferon-β activates multiple signaling cascades in primary human microglia

    Journal of Neurochemistry

    Volume 81, Issue 6, June 2002, Pages: 1361–1371, Mee-Ohk Kim, Qiusheng Si, Jian Nian Zhou, Richard G. Pestell, Celia F. Brosnan, Joseph Locker and Sunhee C. Lee

    Version of Record online : 6 JUN 2002, DOI: 10.1046/j.1471-4159.2002.00949.x

  18. You have full text access to this OnlineOpen article
    Comparative efficacy of switching to natalizumab in active multiple sclerosis

    Annals of Clinical and Translational Neurology

    Volume 2, Issue 4, April 2015, Pages: 373–387, Timothy Spelman, Tomas Kalincik, Annie Zhang, Fabio Pellegrini, Heinz Wiendl, Ludwig Kappos, Larisa Tsvetkova, Shibeshih Belachew, Robert Hyde, Freek Verheul, Francois Grand-Maison, Guillermo Izquierdo, Pierre Grammond, Pierre Duquette, Alessandra Lugaresi, Jeannette Lechner-Scott, Celia Oreja-Guevara, Raymond Hupperts, Thor Petersen, Michael Barnett, Maria Trojano, Helmut Butzkueven and on behalf of the MSBase Investigators and the TOP investigators

    Version of Record online : 27 FEB 2015, DOI: 10.1002/acn3.180

  19. You have free access to this content
    Stromal cells and osteoclasts are responsible for exacerbated collagen-induced arthritis in interferon-β–deficient mice

    Arthritis & Rheumatism

    Volume 52, Issue 12, December 2005, Pages: 3739–3748, Alexandra P. Treschow, Ingrid Teige, Kutty S. Nandakumar, Rikard Holmdahl and Shohreh Issazadeh-Navikas

    Version of Record online : 30 NOV 2005, DOI: 10.1002/art.21496

  20. Non-adherence to interferon-beta therapy in Swedish patients with multiple sclerosis

    Acta Neurologica Scandinavica

    Volume 121, Issue 3, March 2010, Pages: 154–160, A. Cunningham, K. Gottberg, L. Von Koch and J. Hillert

    Version of Record online : 6 JAN 2010, DOI: 10.1111/j.1600-0404.2009.01285.x